What would you like to look for?
Site search
Search filters

Sale of T3 Pharmaceuticals AG to Boehringer Ingelheim

23 November 2023

T3 Pharmaceuticals AG, a biotechnology company with its headquarter in Allschwil, Switzerland has been acquired by Boehringer Ingelheim, a leading family-owned, research-driven biopharmaceutical company based in Ingelheim, Germany...

VISCHER advises Bregal on the acquisition of Netrics Group

22 November 2023

Funds advised by Bregal Unternehmerkapital acquire Netrics Group, one of the largest cloud and modern workplace providers in Switzerland, from Waterland Private Equity. The transaction is accompanied by a reinvestment of the...

Nouscom Raises EUR 67.5 in Oversubscribed Series C Financing Round

14 November 2023

Nouscom AG, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, today announced the completion of its oversubscribed Series C equity financing raising EUR 67.5m (USD 72m) from a syndicate of re-nowned international healthcare investors.

LASCCO and Abionic enter license agreement with Fapon

8 November 2023

LASCCO SA, a biomedical-technology company, and Abionic SA, a nanotechnology company, both based at the Biopôle of Lausanne, Switzerland, entered into a licensing agreement with Fapon Biotech, a global leading life sciences company, based in Dongguan, China, for the use of the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China.

Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients

7 November 2023

Memo Therapeutics AG, a late-stage biotech company developing best-in-class therapeutic antibodies closed a CHF25 million series C financing round led by Pureos Bioventures.

VISCHER advises Swiss Post on its acquisition of a stake in STERIPARC SA.

30 October 2023

Yverdon-les-Bains-based STERIPARC SA is a joint venture for the outsourced processing of medical devices in Western Switzerland. Thanks to this partnership, Swiss Post is expanding its existing logistics services in the healthcare...

LimmaTech Biologics Raises USD 37m Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

12 October 2023

LimmaTech Biologics AG announced the closing of a USD 37m (CHF 33m) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund.

Afinum invests in Hofstetter PCB AG

18 September 2023

Afinum invests in Hofstetter PCB AG (Hofstetter), the leading European provider of printed circuit boards plating and special final finishing services.

Longevity startup Epiterna raises EUR 10million from Prima Materia

8 September 2023

Epiterna SA ("Epiterna") has raised EUR 10 million from Prima Materia, an investment firm founded by Spotify founder Daniel Ek and investor and early Spotify backer Shakil Khan.

Luciole Medical AG acquires Spiegelberg Group

3 July 2023

Luciole Medical, a Swiss medical technology company specialized in brain monitoring, acquires Spiegelberg GmbH & Co. KG (Spiegelberg), an established medical device company and provider of highly specialized devices and consumables for neurosurgery, from SHS Capital.

You are currently offline. Some pages or content may fail to load.